Vatsa, Bela
McNeil, Lisa
Deussen, Peter
Homewood, Steven
Worsnip, Steven
Kosfeld, Frithjof
Funding for this research was provided by:
GlaxoSmithKline Biologicals
Article History
Received: 24 April 2025
Accepted: 12 August 2025
First Online: 22 September 2025
Declarations
:
: Bela Vatsa and Frithjof Kosfeld are employed by and hold financial equities in GSK. Lisa McNeil, Peter Deussen, Steven Homewood and Steven Worsnip received honorarium from GSK for their participation to the advisory board. These authors declare no other financial and non-financial relationships and activities.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.